Hudson Bay Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.15M | Buy |
443,300
+193,300
| +77% | +$1.81M | 0.01% | 423 |
|
|
2025
Q1 | $3.07M | Sell |
250,000
-86,000
| -26% | -$1.06M | 0.01% | 446 |
|
|
2024
Q4 | $4.44M | Sell |
336,000
-89,000
| -21% | -$1.18M | 0.02% | 380 |
|
|
2024
Q3 | $8.18M | Buy |
+425,000
| New | +$8.18M | 0.03% | 221 |
|
|
2023
Q4 | – | Sell |
-1,236,186
| Closed | -$17.9M | – | 789 |
|
|
2023
Q3 | $17.9M | Buy |
1,236,186
+761,186
| +160% | +$11.1M | 0.14% | 79 |
|
|
2023
Q2 | $9.94M | Buy |
+475,000
| New | +$9.94M | 0.07% | 144 |
|
|
2021
Q1 | – | Sell |
-160,000
| Closed | -$3.56M | – | 925 |
|
|
2020
Q4 | $3.56M | Sell |
160,000
-115,000
| -42% | -$2.56M | 0.04% | 277 |
|
|
2020
Q3 | $4.06M | Buy |
275,000
+54,700
| +25% | +$807K | 0.06% | 249 |
|
|
2020
Q2 | $3.26M | Buy |
+220,300
| New | +$3.26M | 0.06% | 244 |
|